ETINO

Main information

  • Trade name:
  • ETINO CAP
  • Dosage:
  • 0.05%
  • Pharmaceutical form:
  • CAP
  • Medicine domain:
  • Humans
  • Medicine type:
  • Allopathic drug

Documents

Localization

  • Available in:
  • ETINO CAP
    India
  • Language:
  • English

Other information

Status

  • Source:
  • Central Drugs Standard Control Organization
  • Last update:
  • 09-08-2016

26-7-2018

Orphan designation:  Peretinoin,  for the: Treatment of hepatocellular carcinoma

Orphan designation: Peretinoin, for the: Treatment of hepatocellular carcinoma

Europe - EMA - European Medicines Agency

27-7-2018

EU/3/11/890 (Kowa Pharmaceutical Europe GmbH)

EU/3/11/890 (Kowa Pharmaceutical Europe GmbH)

EU/3/11/890 (Active substance: Peretinoin) - Transfer of orphan designation - Commission Decision (2018)5056 of Fri, 27 Jul 2018 European Medicines Agency (EMA) procedure number: EMA/OD/003/11/T/01

Europe -DG Health and Food Safety

25-6-2018

Panretin (Eisai Limited)

Panretin (Eisai Limited)

Panretin (Active substance: alitretinoin) - Referral - Commission Decision (2018)4025 of Mon, 25 Jun 2018 European Medicines Agency (EMA) procedure number: EMEA/H/A-31/1446/C/279/37

Europe -DG Health and Food Safety